Skip to main content
. 2024 Oct 30;16(10):6441–6451. doi: 10.21037/jtd-24-694

Table 1. Comparison between patients with and without RT.

Category RT (n=16) No-RT (n=37) P
Age (years) 50 [37–63] 53 [39–64] 0.70
Male 12 (75.0) 22 (59.5) 0.28
APACHE II at ICU admission 18 [13–25] 18 [14–22] 0.73
ARDS 5 (31.3) 7 (18.9) 0.33
Type of brain injury 0.69
   Stroke 6 (37.5) 16 (43.2)
   Post-craniotomy for brain tumors 4 (25.0) 12 (32.4)
   TBI 6 (37.5) 9 (24.3)
Infratentorial lesions 6 (37.5) 17 (45.9) 0.57
SOFA at inclusion 7 [5–8] 5 [4–7] 0.06
GCS at inclusion 9 [5–11] 10 [5–11] 0.81
PaO2/FiO2 ratio at inclusion (mmHg) 178.0 [123.1–288.1] 272.5 [185.8–396.3] 0.009
PaCO2 at inclusion (mmHg) 41.5 [34.0–47.3] 37.0 [32.5–40.0] 0.15
Comorbidity
   COPD 0 2 (5.4) >0.99
   Hypertension 7 (43.8) 14 (37.8) 0.69
   Diabetes mellitus 4 (25.0) 6 (16.2) 0.47
   Coronary heart disease 2 (12.5) 4 (10.8) >0.99
Outcomes
   ICU mortality 4 (25.0) 4 (10.8) 0.22
   In-hospital mortality 5 (31.3) 5 (13.5) 0.15

Categorical variables are shown as number (percentage); continuous variables are shown as median [interquartile range]. RT, reverse triggering; APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive care unit; ARDS, acute respiratory distress syndrome; TBI, traumatic brain injury; SOFA, Sequential Organ Failure Assessment; GCS, Glasgow Coma Scale; PaO2, partial pressure of oxygen; FiO2, fraction of inspired oxygen; PaCO2, partial pressure of carbon dioxide in artery; COPD, chronic obstructive pulmonary disease.

HHS Vulnerability Disclosure